Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Consulting agrmnt
Quarterly results
CC transcript
|
|
Trubion Pharmaceuticals, Inc (TRBN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2011 |
SC 13G/A
| FHM III, LLC has filed a Schedule 13D for Trubion Pharmaceuticals, Inc. |
| 12/10/2010 |
SC 13G/A
| Trubion Pharmaceuticals, Inc reports a 0% stake in Trubion Pharmaceuticals, Inc. |
| 12/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/09/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 11/05/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/05/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/05/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/05/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/05/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/05/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/01/2010 |
4
| ARCH VENTURE FUND V LP (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Sold 2,209,741 shares
@ $0
Sold 14,503 shares
@ $0
Sold 132,802 shares
@ $0 |
|
| 10/29/2010 |
4
| FHM III, LLC (10% Owner) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/29/2010 |
8-K
| Quarterly results |
| 10/28/2010 |
4
| STROMATT SCOTT (SVP and Chief Medical Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| SCHNELL DAVID (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Saks Samuel R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Mohler Kendall (SVP & Chief Scientific Officer) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Mann David A (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Hove Anders D (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Heron Patrick J (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| GILLIS STEVEN (Ex. Chair. & President) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| MCKEREGHAN KATHLEEN (SVP and General Counsel) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| BURRIS MICHELLE (Senior V.P. and C.O.O.) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Disposed/sold 79,732 options to buy
@ $6.52, valued at
$519.9k
Disposed/sold 52,000 options to buy
@ $8.98, valued at
$467k
Disposed/sold 27,500 options to buy
@ $1.33, valued at
$36.6k
Disposed/sold 50,000 options to buy
@ $1.33, valued at
$66.5k
Disposed/sold 45,000 options to buy
@ $3.82, valued at
$171.9k
|
|
| 10/28/2010 |
4
| Brettman Lee R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/28/2010 |
4
| Bencich John (V.P. and CFO) has filed a Form 4 on Trubion Pharmaceuticals, Inc |
| 10/21/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/08/2010 |
8-K
| Form 8-K - Current report |
| 10/08/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/08/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/05/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/05/2010 |
BW
| Levi & Korsinsky, LLP Announces Class Action Lawsuit against Trubion Pharmaceuticals, Inc. and Its Board of Directors |
| 09/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 09/30/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|